123 related articles for article (PubMed ID: 26192396)
1. Biology and oncogenicity of the Kaposi sarcoma herpesvirus K1 protein.
Sousa-Squiavinato AC; Silvestre RN; Elgui De Oliveira D
Rev Med Virol; 2015 Sep; 25(5):273-85. PubMed ID: 26192396
[TBL] [Abstract][Full Text] [Related]
2. Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus.
Wang L; Dittmer DP; Tomlinson CC; Fakhari FD; Damania B
Cancer Res; 2006 Apr; 66(7):3658-66. PubMed ID: 16585191
[TBL] [Abstract][Full Text] [Related]
3. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.
Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W
J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739
[TBL] [Abstract][Full Text] [Related]
4. Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis.
Prakash O; Swamy OR; Peng X; Tang ZY; Li L; Larson JE; Cohen JC; Gill J; Farr G; Wang S; Samaniego F
Blood; 2005 May; 105(10):3987-94. PubMed ID: 15665117
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of the Kaposi's sarcoma-associated herpesvirus K1 protein.
Lee BS; Connole M; Tang Z; Harris NL; Jung JU
J Virol; 2003 Jul; 77(14):8072-86. PubMed ID: 12829846
[TBL] [Abstract][Full Text] [Related]
6. K1 gene transformation activities in AIDS-related and classic type Kaposi's sarcoma: Correlation with clinical presentation.
Tamanaha-Nakasone A; Uehara K; Tanabe Y; Ishikawa H; Yamakawa N; Toyoda Z; Kurima K; Kina S; Tsuneki M; Okubo Y; Yamaguchi S; Utsumi D; Takahashi K; Arakawa H; Arasaki A; Kinjo T
Sci Rep; 2019 Apr; 9(1):6416. PubMed ID: 31015491
[TBL] [Abstract][Full Text] [Related]
7. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
[TBL] [Abstract][Full Text] [Related]
8. Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication.
Lagunoff M; Lukac DM; Ganem D
J Virol; 2001 Jul; 75(13):5891-8. PubMed ID: 11390590
[TBL] [Abstract][Full Text] [Related]
9. Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1.
Wen KW; Damania B
Oncogene; 2010 Jun; 29(24):3532-44. PubMed ID: 20418907
[TBL] [Abstract][Full Text] [Related]
10. KSHV non-structural membrane proteins involved in the activation of intracellular signaling pathways and the pathogenesis of Kaposi's sarcoma.
Abere B; Schulz TF
Curr Opin Virol; 2016 Oct; 20():11-19. PubMed ID: 27518127
[TBL] [Abstract][Full Text] [Related]
11. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B.
Montaner S; Sodhi A; Pece S; Mesri EA; Gutkind JS
Cancer Res; 2001 Mar; 61(6):2641-8. PubMed ID: 11289142
[TBL] [Abstract][Full Text] [Related]
12. Lymphoid hyperplasia and lymphoma in KSHV K1 transgenic mice.
Berkova Z; Wang S; Sehgal L; Patel KP; Prakash O; Samaniego F
Histol Histopathol; 2015 May; 30(5):559-68. PubMed ID: 25301266
[TBL] [Abstract][Full Text] [Related]
13. Expression in a recombinant murid herpesvirus 4 reveals the in vivo transforming potential of the K1 open reading frame of Kaposi's sarcoma-associated herpesvirus.
Douglas J; Dutia B; Rhind S; Stewart JP; Talbot SJ
J Virol; 2004 Aug; 78(16):8878-84. PubMed ID: 15280496
[TBL] [Abstract][Full Text] [Related]
14. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Flore O; Rafii S; Ely S; O'Leary JJ; Hyjek EM; Cesarman E
Nature; 1998 Aug; 394(6693):588-92. PubMed ID: 9707121
[TBL] [Abstract][Full Text] [Related]
15. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
Sodhi A; Montaner S; Gutkind JS
FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
[TBL] [Abstract][Full Text] [Related]
16. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
Carbone A; De Paoli P; Gloghini A; Vaccher E
Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.
Zhang X; Wang JF; Kunos G; Groopman JE
Cancer Res; 2007 Aug; 67(15):7230-7. PubMed ID: 17671191
[TBL] [Abstract][Full Text] [Related]
18. The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma.
Gramolelli S; Schulz TF
J Pathol; 2015 Jan; 235(2):368-80. PubMed ID: 25212381
[TBL] [Abstract][Full Text] [Related]
19. Critical role for endocytosis in the regulation of signaling by the Kaposi's sarcoma-associated herpesvirus K1 protein.
Tomlinson CC; Damania B
J Virol; 2008 Jul; 82(13):6514-23. PubMed ID: 18434405
[TBL] [Abstract][Full Text] [Related]
20. The KSHV K1 Protein Modulates AMPK Function to Enhance Cell Survival.
Anders PM; Zhang Z; Bhende PM; Giffin L; Damania B
PLoS Pathog; 2016 Nov; 12(11):e1005985. PubMed ID: 27829024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
